Here's Why Ocugen Stock Skyrocketed 64.9% in October

Shares of Ocugen (NASDAQ: OCGN) gained 64.9% in October, according to data from S&P Global Market Intelligence. The biotech stock had already been enjoying strong momentum thanks to an increasingly favorable outlook for the Covaxin COVID-19 vaccine it developed in conjunction with Bharat Biotech, and shares posted more big gains following a new regulatory approval and other catalysts. 

OCGN data by YCharts.

Continue reading

Source Fool.com